Overview

A Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia

Status:
Not yet recruiting

Trial end date:
2023-06-30

Target enrollment:

Participant gender:

Summary

A post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia

Phase:

Phase 4

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.